Delepine N, Desbois J C, Delepine G, Cornille H, Mundler O, Fauchet M, Roger B, Laval-Jeantet M
Ann Med Interne (Paris). 1987;138(4):275-7.
The value of quantitative bone scintigraphy, digitised angiography, CT scanning and magnetic resonance imaging in the follow-up of neo-adjuvant chemotherapy for osteogenic osteosarcoma was assessed in 51 patients between 1984 and 1986. Bone scintigraphy was a very sensitive method of detecting bone metastases but of limited value in assessing the response to preoperative chemotherapy. CT scanning was very useful in small and medium sized tumours with predominantly non-calcific involvement of the soft tissue. At present, digitised angiography seems to be the best investigation for following up these patients as shown by the close histo-angiographical correlations. However, magnetic resonance imaging is a very promising method and may in future replace the more invasive aforementioned techniques in this indication.
1984年至1986年间,对51例骨肉瘤患者新辅助化疗后的随访中,评估了定量骨闪烁扫描、数字化血管造影、CT扫描和磁共振成像的价值。骨闪烁扫描是检测骨转移的非常敏感的方法,但在评估术前化疗反应方面价值有限。CT扫描对软组织主要为非钙化受累的中小肿瘤非常有用。目前,数字化血管造影似乎是随访这些患者的最佳检查方法,组织血管造影相关性良好即可证明。然而,磁共振成像非常有前景,未来可能会在该适应症中取代上述侵入性更强的技术。